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Quercetin is a class 2 candidate of the Biopharmaceutics Classification 
System  (BCS), meaning it has a high cellular permeability and low 
solubility. Therefore, a modification in the formulation of quercetin is 
needed to increase its bioavailability. This research aims to modify the 
formulation of quercetin with co-crystalization by adding malonic acid as 
coformer in order to enhance quercetin’s solubility. The plasma 
concentration of quercetin was measured with high performance liquid 
chromatography (HPLC) method. The parameters of bioavailability 
measured were Tmax, Cmax, and AUC0-480mnt. The results obtained were the 
average values of these pharmacokinetic parameters. The average Tmax 
of195 ±174.93 minutes, the average Cmax of 0,56 ± 0,11µg/mL, and the 
average AUC0-480 of 435.62 ± 137.71 µg.minute/mL were obtained from the 
single quercetin compound. After the addition of the coformer malonic acid, 
the average values altered to the average Tmax of 167.50 ± 172.97 minutes, 
the average Cmax of 0.71 ± 0.38 µg/mL, and the average AUC0-480 of 
415.65± 159.01µg.minute/mL. Therefore, it can be concluded that the co-
crystal quercetin - malonic acid does not increase the bioavailability of 
quercetin significantly compared to its single compound according to the 
average values of Tmax, Cmax, and AUC0-480. 
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